Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma. [electronic resource]
Producer: 19960823Description: 293-8 p. digitalISSN:- 0735-7907
- 2',5'-Oligoadenylate Synthetase -- biosynthesis
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Female
- Humans
- Interferon alpha-2
- Interferon-alpha -- adverse effects
- Isotretinoin -- adverse effects
- Killer Cells, Natural -- immunology
- Lymph Nodes -- pathology
- Lymphatic Metastasis
- Male
- Melanoma -- pathology
- Middle Aged
- Necrosis
- Neoplasm Metastasis
- Neoplasm Staging
- Recombinant Proteins
- Skin Neoplasms -- pathology
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.